EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS034-29021 
Organism
Homo sapiens 
Tissue/cell
ECC-1 
Coordinate
chr8:28258350-28260450 
TF binding sites/motifs
Number: 40             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr8:28259755-28259773GGGAGGAGGGAGGGAGGG+6.03
EWSR1-FLI1MA0149.1chr8:28259854-28259872GGAGGGAGAGAAGGAGGG+6.03
EWSR1-FLI1MA0149.1chr8:28259874-28259892GGAGGGAGAGAAGGAGGG+6.03
EWSR1-FLI1MA0149.1chr8:28259332-28259350CCCTCCCTCCCTCCCTCC-6.03
EWSR1-FLI1MA0149.1chr8:28259862-28259880AGAAGGAGGGGAGGAGGG+6.2
EWSR1-FLI1MA0149.1chr8:28259842-28259860GGAGGGAGGGGAGGAGGG+6.34
EWSR1-FLI1MA0149.1chr8:28259815-28259833GGAAGGAAGGAAAGAGAG+7.37
KLF5MA0599.1chr8:28259467-28259477GCCCCGCCCC+6.02
KLF5MA0599.1chr8:28259529-28259539GCCCCGCCCC+6.02
KLF5MA0599.1chr8:28259940-28259950GGGGCGGGGC-6.02
ZNF263MA0528.1chr8:28259851-28259872GGAGGAGGGAGAGAAGGAGGG+10.09
ZNF263MA0528.1chr8:28259871-28259892GGAGGAGGGAGAGAAGGAGGG+10.09
ZNF263MA0528.1chr8:28259906-28259927AAAGCAGGGGAGGGGGAAGGG+6.09
ZNF263MA0528.1chr8:28259831-28259852AGTGGAGGGGCGGAGGGAGGG+6.15
ZNF263MA0528.1chr8:28259771-28259792GGGGGAGGGGTAGATGGGGAG+6.31
ZNF263MA0528.1chr8:28259785-28259806TGGGGAGGAGGGAGGGAGGAG+6.34
ZNF263MA0528.1chr8:28259716-28259737GGTGGAGAGAAGAGGGGAGGA+6.38
ZNF263MA0528.1chr8:28259836-28259857AGGGGCGGAGGGAGGGGAGGA+6.3
ZNF263MA0528.1chr8:28259742-28259763GAGGGAGGAGGTGGGGAGGAG+6.48
ZNF263MA0528.1chr8:28259802-28259823GGAGGAGGGACAGGGAAGGAA+6.56
ZNF263MA0528.1chr8:28259839-28259860GGCGGAGGGAGGGGAGGAGGG+6.59
ZNF263MA0528.1chr8:28259860-28259881AGAGAAGGAGGGGAGGAGGGA+6.5
ZNF263MA0528.1chr8:28259341-28259362CCTCCCTCCCGCCCCACCTCC-6.72
ZNF263MA0528.1chr8:28259764-28259785GAGGGAGGGGGGAGGGGTAGA+6.76
ZNF263MA0528.1chr8:28259734-28259755GGAGGAGGGAGGGAGGAGGTG+6.78
ZNF263MA0528.1chr8:28259753-28259774TGGGGAGGAGGGAGGGAGGGG+6.79
ZNF263MA0528.1chr8:28259738-28259759GAGGGAGGGAGGAGGTGGGGA+6.89
ZNF263MA0528.1chr8:28259911-28259932AGGGGAGGGGGAAGGGGAAAG+6.92
ZNF263MA0528.1chr8:28259843-28259864GAGGGAGGGGAGGAGGGAGAG+6.97
ZNF263MA0528.1chr8:28259748-28259769GGAGGTGGGGAGGAGGGAGGG+7.06
ZNF263MA0528.1chr8:28259728-28259749AGGGGAGGAGGAGGGAGGGAG+7.15
ZNF263MA0528.1chr8:28259745-28259766GGAGGAGGTGGGGAGGAGGGA+7.33
ZNF263MA0528.1chr8:28259760-28259781GAGGGAGGGAGGGGGGAGGGG+7.46
ZNF263MA0528.1chr8:28259848-28259869AGGGGAGGAGGGAGAGAAGGA+7.63
ZNF263MA0528.1chr8:28259868-28259889AGGGGAGGAGGGAGAGAAGGA+7.63
ZNF263MA0528.1chr8:28259863-28259884GAAGGAGGGGAGGAGGGAGAG+7.78
ZNF263MA0528.1chr8:28259788-28259809GGAGGAGGGAGGGAGGAGGAG+7.79
ZNF263MA0528.1chr8:28259799-28259820GGAGGAGGAGGGACAGGGAAG+7.98
ZNF263MA0528.1chr8:28259731-28259752GGAGGAGGAGGGAGGGAGGAG+8.28
ZNF263MA0528.1chr8:28259756-28259777GGAGGAGGGAGGGAGGGGGGA+9.49
Number of super-enhancer constituents: 27             
IDCoordinateTissue/cell
SE_00229chr8:28255250-28262078Adipose_Nuclei
SE_09976chr8:28255478-28260818CD14
SE_10881chr8:28255172-28272037CD20
SE_14002chr8:28257331-28258847CD34_Primary_RO01536
SE_14002chr8:28258909-28259726CD34_Primary_RO01536
SE_14002chr8:28259781-28261125CD34_Primary_RO01536
SE_17678chr8:28257238-28261225CD4p_CD25-_CD45RAp_Naive
SE_24655chr8:28258198-28260517Colon_Crypt_2
SE_26645chr8:28257250-28260912Esophagus
SE_27701chr8:28257858-28261004Fetal_Intestine
SE_28577chr8:28258026-28261038Fetal_Intestine_Large
SE_30513chr8:28257314-28261042Fetal_Muscle
SE_31606chr8:28257277-28260867Gastric
SE_36706chr8:28257941-28259351HMEC
SE_40988chr8:28257374-28260812Left_Ventricle
SE_42550chr8:28257572-28260838Lung
SE_48797chr8:28257261-28260697Right_Atrium
SE_50770chr8:28257241-28260963Sigmoid_Colon
SE_52497chr8:28257253-28260822Small_Intestine
SE_53710chr8:28257295-28261051Spleen
SE_55734chr8:28255502-28261747u87
SE_58644chr8:28219872-28277477Ly1
SE_59813chr8:28219869-28277603Ly4
SE_61002chr8:28174118-28277761HBL1
SE_61739chr8:28219999-28279573Toledo
SE_62508chr8:28220381-28270893Tonsil
SE_67509chr8:28255502-28261747u87
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr82825852828258941
chr82825991528260405
Enhancer Sequence
TTTCACTAGC TGTGCGACCT CTGACAAACC GCTTTGCCTT TCTCAGCCTC CGTTCCTCAG 60
GTGCAAAACG GTTACCTGGG TGGTTATTAA GACATTACCA AGTTACGTGT CACAGCGTCT 120
CTCTACTCTG GATTTCTCAG ATAATGGAAA ACTGACTTCG TGGAGGAAGG CACCGCAACT 180
GAGCCTGCTG TCCTCAGTGT TCATGCAGAT ACCCTCGTGG AGCGCTCCAC GGTTTACGGA 240
AAACTCTTGC ATCGACTGCA TAAATTAGAA AATGAAGCGT AGGAGGCCAG ACTGCCTAGA 300
GTACAGACTC AGATCAGCTT AGTGCGTGAC TGGAGTCTCA TGCAGGCACA CAAACCATAG 360
GGCGATGCTG CCACCGAGTC ATTTCCTGGA TTAGGAGAAG TGGCAGAGAC GCCCTCAGGG 420
ACCACACGTG TCAGATCTCC ACCTCCCAAG CAGCGTTGCC CGGACGCGCC GCTCGGGGCC 480
CAGAGCGCTG CGTGCACGCA GCCTCTAGCA ACCACTTACC GCGTGTGTGC GCATGTGTGT 540
ACGTGTGTGT GCACGTGTGT ATATGTGTAG GTGCACGCAG GCGTGTGCGC GAGTGTGTGT 600
ACGTGTGTGT ACACGCGTGT ATATGTGTGG GTGCGCGAGT GTGTATGTGT GTGACGCGTG 660
TGTACGTGTG TATGCGCACG TGTGAGTGCA CTCGGGTGTA TGTGCTTGTG TGCACGCGCG 720
CGTGTGTATC CGTGTGTGTG CGCGTGTATT TGTGCATGTG TGAGCGCGCC CGTGTGTGCA 780
CGCATGTGTG TACGTATGTG TGTCGTGTGT GCGCGCGTGT ATGTGCGTGT GTGCGCACTC 840
GGGGGTGTAC GTGTGAGTGC GCGCGCGCAC GCGTGTCTGT GTGTGTGGCA TGGGAGGTGG 900
GCGGCAAGGA AAGCAGGCGA GACATTTTTT AAATAAAATA AGAAAAATAA AAGCCCAGCC 960
TTCCAGGGCG TCTTCAGCCA GCCCCTCCCT CCCTCCCTCC CGCCCCACCT CCGGCTCCGG 1020
GGCCGCGGCT CCGGCGCCGC GTTTTCCCGG CCGCCCCGCG CCCGAGGGTT AAAGCTCCCC 1080
CGCCAGGAGT AAACAGCACC CCAGTCGGCA GCCGGCAGCC CCGCCCCTCG GCCCGTTTCC 1140
TGCGCCAGCC CTGGCAACAG GCCCCGCCCT TCGCGACAAG CCCCGCCCCG CGCCATCCGT 1200
CTGGCCCTTC CTGGCGTCCG CCTACTAGCG GCGGGGTCCC GGCCCGTGCC GAGTGCCCAG 1260
CCAGCCCCAA CCCTCTTCCC CCGGGATTCT GCGGCCAGAG CCCCAGCCGA GGGAGGGTGC 1320
GTGCCGCGCA CGTGACTCTT GTTGTAGGCG GGGCCTGCGC AGCGTCGGTG GAGAGAAGAG 1380
GGGAGGAGGA GGGAGGGAGG AGGTGGGGAG GAGGGAGGGA GGGGGGAGGG GTAGATGGGG 1440
AGGAGGGAGG GAGGAGGAGG GACAGGGAAG GAAGGAAAGA GAGTGGAGGG GCGGAGGGAG 1500
GGGAGGAGGG AGAGAAGGAG GGGAGGAGGG AGAGAAGGAG GGGAGGGACG GAGGGGAAAG 1560
CAGGGGAGGG GGAAGGGGAA AGCAGGGGAA GGGGCGGGGC GAGGGTCTGG CCTAGTCTCC 1620
TCCAGCTTCG TGGAGCCCGC CTGGGGCGCC GCTCTCCCGC CCCCGCCCCT CCACGGGTCC 1680
AGCTGGGAAC TGGCTATGGC CTCGCCGCCC GGCGAGGGCT GCAGTGGGTT CCCCGACGAC 1740
TTTGCCGCGG TTGCTGCTTC TGCCAGCGCA GCCTCGGAGC GCTGCCCGGC TGCAGGGCTC 1800
TCACCTCTTC CCCAGGTCCC TGCTCAGCAG AGCCTCTTAA GCTTCCTGCC TGTGTCCACA 1860
GAACCCGACA TCTCAAGCCC CCTGAACGCA CAGGCTCCTG CTGCATAAAC ACCCCGCCCT 1920
CCTGCCTCCT GCACACACAG GCCTACATTG TAGGGCCTCC CACGCCTCTC CGTTCCTGGA 1980
ATGGAGCTCA CCTAACCCTG TGCTCGTCCT GCTGTCTTCT CTAAGGGTGG GGAAACTTGA 2040
GGTTCAGAAA GCTGGAAGGA TTTCAGTGTG CACCATACAT CGACCACACA ACAGTCCCAC 2100